Codagenix

@Codagenix

Viral design Platform for Vaccine and Oncolytic therapy development. Vaccine Pipeline: Flu, RSV, Dengue. Oncology Pipeline: Triple-Negative Breast Cancer

Farmingdale, NY
Vrijeme pridruživanja: srpanj 2013.

Tweetovi

Blokirali ste korisnika/cu @Codagenix

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @Codagenix

  1. 1. lis 2019.

    Codagenix adds new addition to our team: Sybil Tasker, MD, MPH, recently joined as Chief Medical Officer. Read the full press release here:

    Poništi
  2. 1. lis 2019.

    Codagenix at . Oct 3-6 our CMO Sybil Tasker and CSO Steffen Mueller will be presenting our work to the clinical community on our live-attenuated vaccine (poster 2777) & our balanced, tetravalent vaccine (poster 2754).

    Poništi
  3. 12. lis 2017.

    Joining the fight against with a promising vaccine candidate; planning for a Ph1 by Q4-2018

    Poništi
  4. 12. lis 2017.

    Joining the fight against with a promising vaccine candidate; planning for a Ph1 by Q4-2018

    Poništi
  5. proslijedio/la je Tweet

    New start-up () is fighting disease right from a virus’s genetic code:

    Poništi
  6. 28. velj 2017.
    Poništi
  7. 28. velj 2017.

    Featured in a Recent Market Map of Synthetic Biology Companies

    Poništi
  8. 10. sij 2017.

    Multi-season efficacy and immunogenicity of CodaVax intranasal Influenza vaccine

    Poništi
  9. 9. sij 2017.

    Multi-season efficacy and immunogenicity of CodaVax intranasal vaccine

    Poništi
  10. 9. sij 2017.

    Discussing our vaccine @ meetings at - Synthesized in <27 days; demonstrated safety & efficacy in vivo

    Poništi
  11. 9. sij 2017.

    Demonstration of multi-season efficacy and immunogenicity of CodaVax intranasal vaccine

    Poništi
  12. 8. sij 2017.
    Poništi
  13. proslijedio/la je Tweet
    Poništi
  14. 29. stu 2016.

    Unlike an inert inactivated vaccine; Our is a PERFECT-antigenic match to the target, providing ALL antigens to immune system

    Poništi
  15. 29. stu 2016.

    Unlike the DNA or VLP vaccines; Our is a PERFECT-antigenic match to the target, providing ALL antigens to the immune system

    Poništi
  16. 29. stu 2016.

    Using our whole-viral genome de-optimization approach we synthesized our , in 27 days! now in in vivo testing

    Poništi
  17. proslijedio/la je Tweet
    Poništi
  18. 21. stu 2016.

    Using our whole-viral genome de-optimization approach we synthesized our , in 27 days now in in vivo testing

    Poništi
  19. 21. stu 2016.
    Poništi
  20. 21. stu 2016.
    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·